1-3 of 3
Claudio Denzlinger
Close
Sort by
Journal Articles

Phase 3, Placebo-Controlled, ASPIRE Study (TRC114968) of Eltrombopag (EPAG) Treatment of Thrombocytopenia (TCP) in Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Assessment of Clinical Benefit, Safety, and Tolerability

Moshe Mittelman, MD, Uwe Platzbecker, MD, Boris V Afanasyev, Professor, Sebastian Grosicki, MD PhD, Raymond SM Wong, MD, Achilles Anagnostopoulos, MD, Benjamin Brenner, MD, Claudio Denzlinger, MD, Giuseppe Rossi, MD, Arnon Nagler, MD MSc, Ana Isabel Rosell Mas, PhD, Frank Mannino, PhD, Nicole L. Stone, PhD, Geoffrey Chan, MD, Yasser Mostafa Kamel, MD MSc, MBA, Dominik L.D. Selleslag, MD
Journal: Blood
Blood (2015) 126 (23): 1661.
https://doi.org/10.1182/blood.V126.23.1661.1661
Published: 2015
Journal Articles

Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

Clinical Trials & Observations
Sergio Amadori, Stefan Suciu, Ulrich Jehn, Roberto Stasi, Xavier Thomas, Jean-Pierre Marie, Petra Muus, Francois Lefrère, Zwi Berneman, George Fillet, Claudio Denzlinger, Roel Willemze, Pietro Leoni, Giuseppe Leone, Marco Casini, Francesco Ricciuti, Marco Vignetti, Filip Beeldens, Franco Mandelli, Theo De Witte, for the EORTC/GIMEMA Leukemia Groups
Journal: Blood
Blood (2005) 106 (1): 27–34.
https://doi.org/10.1182/blood-2004-09-3728
Published: 2005
Journal Articles

Chemotaxis and transendothelial migration of CD34 + hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1

Frank Bautz, Claudio Denzlinger, Lothar Kanz, Robert Möhle
Journal: Blood
Blood (2001) 97 (11): 3433–3440.
https://doi.org/10.1182/blood.V97.11.3433
Published: 2001